Bell Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bell Investment Advisors's BMY Position: Q2 2026 in Review
Bell Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2026, selling an estimated $7K and leaving 420 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #422.
Bell Investment Advisors first reported a position in BMY in Q3 2021 and has held it in 19 quarters since. The position peaked at $94K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bell Investment Advisors held 420 shares of Bristol-Myers Squibb worth $24.2K as of Q2 2026.
- Bell Investment Advisors sold 122 Bristol-Myers Squibb shares in Q2 2026, an estimated $7K.
- Bristol-Myers Squibb made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #422 holding.
- Bell Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 19 quarters since.
- Bell Investment Advisors's Bristol-Myers Squibb position peaked at $94K in Q2 2022.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.